About: Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1997 (uk) article scientifique publié en 1997 (fr) im März 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1997 (ast) scientific article published on 01 March 1997 (en)
publication date	wds:Q73155654-EFA16A74-91B3-4D29-A50B-14DBC3BC469B
publication date	1997-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73155654-FF52284F-10B3-4323-98C1-D7C5D2DFC1F3
language of work or name	English
cites work	wds:Q73155654-2CEED3AC-2B21-4604-ABCE-A125AD91E09A wds:Q73155654-468A0E8C-3A3F-45C9-A7E4-4258CBC16757 wds:Q73155654-4CD1967D-9843-4681-AE47-D255D0AEF536 wds:Q73155654-70A3EEA4-4D7A-483F-B3F2-99F7CB0C5D59 wds:Q73155654-9F89681E-9E67-407C-96A2-40E52170F27D wds:Q73155654-C8D92E7C-BAC3-45E4-87A1-BDFC02DDB486 wds:Q73155654-D691D9F7-6BF9-41E1-974D-5A84A57DCD21 wds:Q73155654-D8D56E3A-17B2-40A6-B299-C7AF9EC5E133 wds:Q73155654-E975A54E-9232-4F3D-A7A2-2A550E3C12E6 wds:Q73155654-F0B347AD-6A9D-497D-92BA-1DEEFD62ABAB wds:Q73155654-F3354C08-D070-4AC2-80A2-7AA38946D577 wds:Q73155654-F89246C7-0DD2-4BD9-97FA-30DB63A49DC0 wds:Q73155654-FCD4A5AC-E6A4-438D-8910-FA16E6FDD0BE wds:Q73155654-FEB0AAD6-3037-4749-8F4F-49E19DE04E1E wds:Q73155654-FFE16E7B-748B-4D30-A5B4-0455F48064E6
cites work	Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients Amylo-1,6-glycosidase/4-α-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy Cardiac involvement in glycogen storage disease type III Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. II. Clinical methodology and feasibility Gross cardiac involvement in glycogen storage disease type 3 Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy Glycogen storage disease type III associated with ventricular tachycardia
author name string	wds:Q73155654-0955AFA5-CB25-4ABD-AAAB-05583241A648 wds:Q73155654-346ED6C0-A0AC-4788-AE92-EE842F547CB3 wds:Q73155654-859DCEE4-880C-4863-87B9-55595DA27163 wds:Q73155654-CD810548-8EAC-4041-9901-DE4CDB6159B4 wds:Q73155654-F63BEABE-6314-444B-9024-5CE15AA9735D
author name string	J V Leonard P J Lee W J McKenna M Burch K Baig
rdfs:label	Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III (en) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III (nl)
skos:prefLabel	Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III (en) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III (nl)
name	Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III (en) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III (nl)
author	wds:Q73155654-2A4E10E4-2493-43CC-A8F8-43B7D89F7838
author	John Deanfield
title	wds:Q73155654-6DBB3CF3-1D51-42F8-A910-53623E55CC33
title	Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III (en)
page(s)	wds:Q73155654-55329D6E-6E02-4803-AFE3-B65C2EF24428
page(s)	834-838
instance of	wds:Q73155654-E614BCDB-1684-4197-B4F1-D003BCEA2147
instance of	scholarly article
main subject	wds:Q73155654-BF55CD16-F622-45CA-95D9-409A84E68CC1 wds:Q73155654-E120DBC6-E942-4F5D-BA11-BE3617EED694
main subject	left ventricular hypertrophy hypertrophic cardiomyopathy
PubMed ID	wds:Q73155654-D4688955-C040-4A10-998E-0ABA825C8C13
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9070576
PubMed ID	9070576
published in	wds:Q73155654-02D5B868-3C00-41ED-9C39-D76E4BC00B7E
published in	American Journal of Cardiology
issue	wds:Q73155654-0345F644-3A34-4C49-8938-995160C5D061
volume	wds:Q73155654-A58E1A9C-A3A5-45F7-ABBB-582C19BE3894
issue	6
volume	79
DOI	wds:Q73155654-7FE53A02-8135-451A-A60E-F885F92CC832
DOI	http://dx.doi.org/10.1016/S0002-9149(96)00885-5
DOI	10.1016/S0002-9149(96)00885-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73155654
is cites work of	Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Characterization of a canine model of glycogen storage disease type IIIa Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient Mouse model of glycogen storage disease type III. Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet Correction of glycogen storage disease type III with rapamycin in a canine model. Preclinical Development of New Therapy for Glycogen Storage Diseases Inborn errors of energy metabolism associated with myopathies Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants Disorders of carbohydrate metabolism Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time Dietary management in glycogen storage disease type III: what is the evidence? Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene Liver Transplantation in a Myopathic Patient with Glycogen Storage Disease Type IIIa and Decompensated Cirrhosis. Glycogen storage disease type III in Inuit children Blood lipids and endothelial function in glycogen storage disease type III
is cites work of	wds:Q39234934-1E141AD7-A9E9-4267-8A5F-A0FC48C1B1B2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software